Makhtar Camara

Associate Professor 

Université Cheikh Anta Diop de Dakar (UCAD) / Institut de Recherche en Santé de Surveillance Epidémiologique et de Formation [Institute for Health Research, Epidemiological Surveillance and Training] (IRESSEF), Senegal

Email: camaramakhtar@yahoo.fr / makhtar.camara@iressef.org / makhtar.camara@ucad.edu.sn

VALIDATE Role:

Network Associate

Research Keywords: 

Immunology, Microbiology

Biography:

I am Associate Professor of Bacteriology and Virology in Cheikh Anta DIOP University, Dakar, Senegal. I work in the fields of microbiology and immunology in Aristide Le Dantec University Hospital as well as in IRESSEF. My main topic is study of correlates of immune protection against HIV-infection among HIV-exposed seronegative partners in HIV heterosexual discordant couples in Senegal. This work was supported by the Institute of Tropical Medicine (ITM), Antwerp, Belgium, where I was trained on several immunological techniques such as enhanced ELISpot assay using exogenous cytokines, IL-7/IL-15 in order to detect low level T-cell responses and flow cytometry analyses (phenotyping and intracellular cytokine staining). In addition, I was involved in the management of the immunological aspects of the TB021 MVA85A and Ebola vaccine trials conducted recently in Dakar, Senegal.

Key Publications:

• Camara M, Dieng A, Diop A, Diop A, Diop A, Boiro D, Diouf JPN, Fall A, Ndiaye O, Niang M, Boye CSB. Antibiotic resistance of bacteria responsible of acute respiratory tract infections in children. Microbiologia Medica 2017; 32:6489.
• Ba-Diallo A, Walbang OG, Camara M, Lo-Lo S, Ayorinde A, Niang A, Mboup S, Gaye-Diallo A, de Jong BC, Gehre F. Molecular genotypes of Mycobacterium tuberculosis strains circulating in Dakar by spoligotyping. AJMR 2016; 10(35):1460-6.
• Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, Dièye S, Dieye TN, Esmail H, Goliath R, Huygen K, January V, Ndiaye I, Oni T, Raine M, Romano M, Satti I, Sutton S, Thiam A, Wilkinson KA, Mboup S, Wilkinson RJ, McShane H, for the MVA85A 030 trial investigators. Safety, immunogenicity and efficacy of the candidate tuberculosis vaccine MVA85A in healthy HIV-1-infected adults: A randomized, placebo-controlled phase 2 trial. Lancet Respir Med 2015; 3(3):190-200.
• Camara M, Dieng A, Boye CSB. Antibiotic susceptibility of Streptococcus pyogenes isolated from respiratory tract infections in Dakar, Senegal. Microbiology Insights 2013:6 71-75.
• Jennes W, Verheyden S, Mertens JW, Camara M, SeydiM, Dieye TN, Mboup S, Demanet C, Kestens L. Response: KIR/HLA ligand incompatibility in HIV-1 transmission and importance of the ‘missing self’ model. Blood 2013; 122(11):1984-5.